Cargando…
pERK1/2 silencing sensitizes pancreatic cancer BXPC-3 cell to gemcitabine-induced apoptosis via regulating Bax and Bcl-2 expression
BACKGROUND: Our previous study has demonstrated that knockdown of activated ERK1/2(pERK1/2) sensitizes pancreatic cancer cells to chemotherapeutic drug gemcitabine (Gem) treatment. However, the details of this survival mechanism remain undefined. It has also shown that Bcl-2 confers resistance and B...
Autores principales: | Wang, Min, Lu, Xingjiao, Dong, Xueguang, Hao, Fengyun, Liu, Zimin, Ni, Guangzhen, Chen, Dong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4337256/ https://www.ncbi.nlm.nih.gov/pubmed/25880226 http://dx.doi.org/10.1186/s12957-015-0451-7 |
Ejemplares similares
-
High glucose increases LPS-induced DC apoptosis through modulation of ERK1/2, AKT and Bax/Bcl-2
por: Feng, Mei, et al.
Publicado: (2014) -
Bax, Bcl-2, and Bax/Bcl-2 as prognostic markers in acute myeloid leukemia: are we ready for Bcl-2-directed therapy?
por: Kulsoom, Bibi, et al.
Publicado: (2018) -
The prognostic significance of apoptosis-associated proteins BCL-2, BAX and BCL-X in clinical nephroblastoma
por: Ghanem, M A, et al.
Publicado: (2001) -
Silencing of the hTERT gene through RNA interference induces apoptosis via Bax/Bcl-2 in human glioma cells
por: WANG, TUO, et al.
Publicado: (2012) -
The Action of Bax and Bcl-2 on T Cell Selection
por: Williams, Owen, et al.
Publicado: (1998)